Prime Medicine, a third-generation Crispr company, may test the choppy waters of the stock market with an IPO. In the current environment, companies may do better staying private than going public. But Prime Medicine may Read more…
Welcome to Technical Tuesday, a weekly report where we highlight some of the most interesting markets that will hopefully appease technical analysts and traders alike. In this week’s edition, we are getting technical on the Read more…
San Francisco Fed President Mary Daly said Fed needs to raise interest further and hold restrictive policies in place until it’s “truly done” on bring back inflation to 2% target. “Those interest rate increases slow Read more…
The Swiss bank is due to unveil its turnaround plan on Oct. 27, a deadline employees say is too far off given the circumstances. For Credit Suisse (CS) – Get Credit Suisse Group American Depositary Read more…
The latest US employment report will rock financial markets at 12:30 GMT Friday. With the Fed actively trying to weaken the labor market, the stakes are very high. However, it seems like Powell won’t get Read more…
The Reserve Bank of Australia raised its rate by 25 points to 2.6%, against an expected increase to 2.85%. Previously, the rate had been hiked by 50 points four times since June. The same decision Read more…
The Euro accelerated higher on Tuesday (up 1% since Asian opening) boosted by improved risk sentiment that kept dollar under pressure for the second straight day. Hawkish comments from ECB policymaker further fuel expectations for Read more…
Markets Should we call it euphoria or are we simply attending a long overdue short-squeeze after a protracted risk sell-off? Whatever, it has been quite a long time since European equities gained 2.5% to 3.5% Read more…
Daily Pivots: (S1) 1.4982; (P) 1.5145; (R1) 1.5239; More… EUR/AUD’s rally resumed after brief retreat and intraday bias is back on the upside. Decisive break of 1.5396 key resistance carry larger bullish implication. Next target Read more…
Daily Pivots: (S1) 144.06; (P) 144.67; (R1) 145.17; More… No change in USD/JPY’s outlook as range trading continues. Intraday bias stays neutral for the moment. Further rally is expected as long as 139.37 resistance turned Read more…